Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The prevalence and incidence of systemic lupus erythematosus (SLE) in selected cities from three Commonwealth of Independent States countries (the Russian Federation, Ukraine and Kazakhstan).
Nasonov E, Soloviev S, Davidson JE, Lila A, Ivanova R, Togizbayev G, Omarbekova Z, Shevchuk S, Iaremenko O, Gnylorybov A, Smailova Z, Chernogolov V, Malynovska K, Vasylyev A, Pereira MH. Nasonov E, et al. Among authors: togizbayev g. Lupus. 2014 Feb;23(2):213-9. doi: 10.1177/0961203313512881. Epub 2013 Nov 19. Lupus. 2014. PMID: 24255073 Free article.
Standard medical care of patients with systemic lupus erythematosus (SLE) in large specialised centres: data from the Russian Federation, Ukraine and Republic of Kazakhstan (ESSENCE).
Nasonov E, Soloviev S, Davidson JE, Lila A, Togizbayev G, Ivanova R, Baimukhamedov Ch, Omarbekova Zh, Iaremenko O, Gnylorybov A, Shevchuk S, Vasylyev A, Pereira MH. Nasonov E, et al. Among authors: togizbayev g. Lupus Sci Med. 2015 Feb 19;2(1):e000060. doi: 10.1136/lupus-2014-000060. eCollection 2015. Lupus Sci Med. 2015. PMID: 25717382 Free PMC article.
Systemic lupus erythematosus and associated healthcare resource consumption in selected cities from the Russian Federation, Republic of Kazakhstan and Ukraine: the ESSENCE study.
Nasonov E, Soloviev S, Davidson JE, Lila A, Togizbayev G, Ivanova R, Baimukhamedov C, Omarbekova Z, Iaremenko O, Gnylorybov A, Shevchuk S, Vasylyev A, Makarova J, Tariq L. Nasonov E, et al. Among authors: togizbayev g. J Med Econ. 2018 Oct;21(10):1006-1015. doi: 10.1080/13696998.2018.1499518. Epub 2018 Jul 25. J Med Econ. 2018. PMID: 29992845 Free article.
New classification criteria for juvenile idiopathic arthritis.
Chen K, Zeng H, Togizbayev G, Martini A, Zeng H. Chen K, et al. Among authors: togizbayev g. Int J Rheum Dis. 2023 Oct;26(10):1889-1892. doi: 10.1111/1756-185X.14813. Int J Rheum Dis. 2023. PMID: 37807617 No abstract available.
Inequities in access to biologic and synthetic DMARDs across 46 European countries.
Putrik P, Ramiro S, Kvien TK, Sokka T, Pavlova M, Uhlig T, Boonen A; Working Group ‘Equity in access to treatment of rheumatoid arthritis in Europe’. Putrik P, et al. Ann Rheum Dis. 2014 Jan;73(1):198-206. doi: 10.1136/annrheumdis-2012-202603. Epub 2013 Mar 6. Ann Rheum Dis. 2014. PMID: 23467636